Neogen Chemicals - Battery Chemicals Execution Remains The Key: Nirmal Bang

Nirmal Bang Report

Key Points

1. We recently interacted with the management of Neogen Chemicals Ltd. to understand better the synergies derived from BuLi acquisition and update on battery business.

2. Neogen Chemicals is aiming for ~30% market share in electrolyte segment in India by FY28. ‘China plus one’ theme should aid growth in salts segment.

3. If executed well, earnings growth can be ~four times over FY23-FY27, in our view. Implied price-to-earning is ~20 times FY27E at current market price.

4. Near-term weakness in existing bromine business due to tepid demand in pharma and agrochemicals could offer better entry point.

5. Maintain 'Accumulate' with revised target price of Rs 1,800 (earlier Rs1,600), d at 40 times PE on September 25E earnings.

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.